Navigation Links
New investment fund will advance late-stage vaccines, other global health technologies
Date:9/23/2013

Cooper-Hohn, Chair of the Children's Investment Fund Foundation (CIFF). "Relatively little investment goes to the development of new drugs, vaccines and diagnostics specifically targeted at children in developing countries where child mortality is most dire. CIFF is very pleased to be a major investor into the Global Health Investment Fund, which promises to deliver new finance and focus to this neglected area."

Additional Partner Endorsements

Christopher Egerton-Warburton, GHIF Fund Manager: "GHIF joins the family of innovative financing mechanisms in global health. Although this is the first investment fund dedicated to global health R&D, we hope this will serve as a pilot for future funds of this type in global health and other sectors."

Charlotte Petri Gornitzka, Director General, Swedish International Development Cooperation Agency (Sida): "Sweden and Sida are excited to be part of this groundbreaking initiative where private capital is put to work for development. It shows the magnitude of results that can be reached when aid, business and philanthropy work hand in hand."

Dr. Norbert Kloppenburg, KfW Executive Board member: "Thanks to the Fund, more people will have access to improved health carewhile at the same time a financial return will be generated for investors. The projects supported by the fund will improve the health status of many people, especially women and children, and will thus contribute to poverty alleviation."

Dr. Moncef Slaoui, Chairman Vaccines and R&D, GlaxoSmithKline: "I am convinced the GHIF will be instrumental in helping bring cutting edge innovation and solutions to diseases of the developing world and this is one reason why we are participating. This collaboration demonstrates that with an innovative structure, a fund with a humanitarian focus can appeal to a broader range of investors."

Jeffrey A. Chodakewitz, MD, Vice President, Global Clinical Development, Merck:
'/>"/>

Contact: Colleen Harris
colleen@colleenharris.co.uk
44-207-223-4512
Grand Challenges Canada
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. ChipCares handheld analyzer attracts one of Canadas largest-ever healthcare angel investments
2. Wexford Science & Technology Makes $150 Million Investment in Wake Forest Innovation Quarter
3. OGIs investment in cytognomix contributes to the Shannon Human Splicing Pipelines success
4. UNC Charlotte researcher leads effort to forecast optimal energy investments
5. Medbox Executes $6 Million Equity Transaction with Private Investment Firm
6. FASEB joins President Obama in urging Congress to sustain investments in research and innovation
7. Nottingham part of £20m investment for UK synthetic biology
8. US investment in biomedical and health research on downward trend
9. AZTI-Tecnalia leads 2 research projects on bluefin tuna with 1.5 million euros investment
10. Amarantus BioSciences to Present at the National Investment Banking Associations (NIBA)122nd Conference in New York City
11. $50 million NSF grant to advance cyberinfrastructure for big data in life sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... YORK , Dec. 23, 2014  Since its launch ... helped thousands of people to eliminate the pain of ... the antiquated system with their own biometrics fused to ... remember usernames and passwords, Hoyos Labs , the ... announced today that it is offering the app for ...
(Date:12/22/2014)... 22, 2014  NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market, ... consultant, Apollo Robbins for the 2015 International ... Apollo Robbins will be at ... 2015, demonstrating some of his famous theft techniques to ...
(Date:12/22/2014)... Research and Markets ( ... the "The Global Watermarking and Fingerprinting ... http://photos.prnewswire.com/prnh/20130307/600769 ... the global digital media watermarking and fingerprinting ... piracy by securely and invisibly embedding identifiable ...
Breaking Biology News(10 mins):1U Offers Best Solution to the Username / Password Dilemma: For FREE! 21U Offers Best Solution to the Username / Password Dilemma: For FREE! 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4The Global Watermarking and Fingerprinting Markets 2
... , Bremerhaven, 19 September 2011. Earth warming will presumably ... the South Pacific Ocean. This is the conclusion drawn ... 50-million-year-old clam shells and wood from the Antarctic. The ... also a climate rhythm over the South Pacific during ...
... Taiwan have confirmed a bidirectional relation between schizophrenia and ... a journal of the International League Against Epilepsy (ILAE), ... more likely to develop schizophrenia and those with schizophrenia ... epilepsy. Prior clinical studies have shown a ...
... have shown, for the first time in an animal, that ... parts of the central nervous system. , They subjected rainbow ... a whitening agent in many products including paints, some personal ... industry. They found that the particles caused vacuoles (holes) to ...
Cached Biology News:50-million-year-old clam shells provide indications of future of El Nino phenomenon 2Study finds bidirectional relationship between schizophrenia and epilepsy 2
(Date:12/24/2014)... The report expects global cell isolation ... It also provides a carefully analyzed data about the ... the market. , Full Copy of Report @ ... market for cell expansion will keep witnessing growth at ... growth to be driven by rapid technological advancements, government ...
(Date:12/24/2014)... China Biologic Products, Inc. (NASDAQ: CBPO, ... integrated plasma-based biopharmaceutical company in China ... Shandong Taibang Biological Products Co. Ltd., has received ... Food and Drug Administration (the "CFDA") for its ... in the Company,s public filings, the CFDA inspected ...
(Date:12/24/2014)... , December 23, 2014 ... Algeria , out today and available for free download ... actors driving change and growth in the sector today. ... scored notable successes has been in developing a homegrown pharmaceutical ... percent local production still remains some way off. A cursory ...
(Date:12/24/2014)... , Dec. 23, 2014  Rock Creek Pharmaceuticals, ... it has filed a Clinical Trial Application (CTA) with ... products Regulatory Agency (MHRA) seeking regulatory approval to initiate ... molecule, Anatabine Citrate. Contingent on the Company ... a Phase I trial to assess the safety, tolerability ...
Breaking Biology Technology:The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3PharmaBoardroom Releases New Algeria Pharmaceuticals Report 2PharmaBoardroom Releases New Algeria Pharmaceuticals Report 3Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 2Rock Creek Pharmaceuticals Files Clinical Trial Application in the UK for Clinical Trials of Anatabine Citrate Formulations 3
... Osteotech, Inc.,(Nasdaq: OSTE ), a leader ... medicine, announced today that the United States Patent ... U.S. Patent No.,5,676,146. The ,146 patent covers mixtures ... a radiopaque material, such as nondemineralized,or partially demineralized ...
... and biotechnology research companies invested a record $58.8,billion ... new life-changing,medicines and vaccines -- an increase of ... the Pharmaceutical Research and Manufacturers of,America (PhRMA) and ... coincides,with PhRMA,s 50th anniversary, which it observes today., ...
... China,s State Food and Drug,Administration has approved ... confocal microscope in the Peoples Republic of ... Rochester, New York-based medical device and,information company ... Lucid,s VivaScope(R) reflective confocal microscopes (RCM) ...
Cached Biology Technology:U.S. Patent Office Confirms Validity of Osteotech's U.S. Patent No. 5,676,146 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 2R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007 3Lucid's VivaScope(R) Reflective Confocal Microscope Approved for Sale in China 2Lucid's VivaScope(R) Reflective Confocal Microscope Approved for Sale in China 3
... Variable Speed Rocker, with 12" x 14" table; ... x 14" table; 220V. The VSR-50 Variable ... for any lab. The VSR-50 provides a rhythmic ... a gentle to vigourous movement. This makes it ...
...
...
...
Biology Products: